» Articles » PMID: 32704509

Variations in Seasonal Influenza Vaccine Effectiveness Due to Study Characteristics: A Systematic Review and Meta-analysis of Test-Negative Design Studies

Overview
Date 2020 Jul 25
PMID 32704509
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Study characteristics influence vaccine effectiveness (VE) estimation. We examined the influence of some of these on seasonal influenza VE estimates from test-negative design (TND) studies.

Methods: We systematically searched bibliographic databases and websites for full-text publications of TND studies on VE against laboratory-confirmed seasonal influenza in outpatients after the 2009 pandemic influenza. We followed the Cochrane Handbook for Systematic Reviews of Interventions guidelines. We examined influence of source of vaccination information, respiratory specimen swab time, and covariate adjustment on VE. We calculated pooled adjusted VE against H1N1 and H3N2 influenza subtypes, influenza B, and all influenza using an inverse-variance random-effects model.

Results: We included 70 full-text articles. Pooled VE against H1N1 and H3N2 influenza subtypes, influenza B, and all influenza was higher for studies that used self-reported vaccination than for those that used medical records. Pooled VE was higher with respiratory specimen collection within ≤7 days vs ≤4 days of symptom onset, but the opposite was observed for H1N1. Pooled VE was higher for studies that adjusted for age but not for medical conditions compared with those that adjusted for both. There was, however, a lack of statistical significance in almost all differences in pooled VE between compared groups.

Conclusions: The available evidence is not strong enough to conclude that influenza VE from TND studies varies by source of vaccination information, respiratory specimen swab time, or adjustment for age/medical conditions. The evidence is, however, indicative that these factors ought to be considered while designing or evaluating TND studies of influenza VE.

Citing Articles

Effectiveness of influenza vaccination in preventing confirmed influenza cases and hospitalizations in Northern Spain, 2023/24 season: A population-based test-negative case-control study.

Martinez-Baz I, Navascues A, Trobajo-Sanmartin C, Pozo F, Fernandez-Huerta M, Olazabal-Arruiz M Int J Infect Dis. 2024; 151:107364.

PMID: 39694231 PMC: 11735411. DOI: 10.1016/j.ijid.2024.107364.


Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine.

Cowling B, Okoli G Drugs. 2024; 84(9):1013-1023.

PMID: 39167316 PMC: 11438668. DOI: 10.1007/s40265-024-02083-8.


Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza among Chinese elderly: a test-negative design.

Yang T, Tang L, Li P, Li B, Ye L, Zhou J BMC Geriatr. 2024; 24(1):404.

PMID: 38714944 PMC: 11077745. DOI: 10.1186/s12877-024-05003-3.


The evolutionary footprint of influenza A subtype H3N2 strains in Bangladesh: implication of vaccine strain selection.

Rahman S, Hasan M, Alam M, Uddin K, Moni S, Rahman M Sci Rep. 2022; 12(1):16186.

PMID: 36171388 PMC: 9519982. DOI: 10.1038/s41598-022-20179-7.


Live-attenuated influenza vaccine effectiveness against hospitalization in children aged 2-6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14-2015/16.

Boddington N, Mangtani P, Zhao H, Verlander N, Ellis J, Andrews N Influenza Other Respir Viruses. 2022; 16(5):897-905.

PMID: 35531630 PMC: 9343328. DOI: 10.1111/irv.12990.


References
1.
Jimenez-Jorge S, Savulescu C, Pozo F, DE Mateo S, Casas I, Ledesma J . Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. Vaccine. 2012; 30(24):3595-602. DOI: 10.1016/j.vaccine.2012.03.048. View

2.
Valenciano M, Kissling E, Reuss A, Jimenez-Jorge S, Horvath J, Donnell J . The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2). Vaccine. 2015; 33(24):2813-22. DOI: 10.1016/j.vaccine.2015.04.012. View

3.
Jackson M, Phillips C, Benoit J, Kiniry E, Madziwa L, Nelson J . The impact of selection bias on vaccine effectiveness estimates from test-negative studies. Vaccine. 2017; 36(5):751-757. DOI: 10.1016/j.vaccine.2017.12.022. View

4.
Pebody R, Warburton F, Ellis J, Andrews N, Potts A, Cottrell S . Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results. Euro Surveill. 2016; 21(38). PMC: 5073201. DOI: 10.2807/1560-7917.ES.2016.21.38.30348. View

5.
Flannery B, Zimmerman R, Gubareva L, Garten R, Chung J, Nowalk M . Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. J Infect Dis. 2016; 214(7):1010-9. PMC: 5812259. DOI: 10.1093/infdis/jiw181. View